Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2024 10:00 ET | Source: Aummune

Aummune Announces Results from Phase 1 Trial of its Novel AM003 Immunotherapy for the Treatment of Solid Tumors

AM003 is a first-in-class functional oligonucleotide in development for the treatment of solid tumorsFirst –in-human, monotherapy dose-escalation Phase 1 trial has been successfully completedThe study...
May 28, 2024 08:00 ET | Source: Aummune

Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003

AM003 is a first-in-class functional oligonucleotide in development for the treatment of solid tumorsTrial-in-Progress poster to provide an overview of the Phase 1 dose-escalation study with AM003 in...